Benzoyl peroxide and adapalene fixed combination: A novel agent for acne

British Journal of Dermatology

Volumn 161, Issue 5, 2009, Pages 971-976

  Layton, A M ^a   Eady, E A ^a  

^a HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acne; Adapalene; Antibiotics; Bacterial resistance; Benzoyl peroxide

Indexed keywords

ADAPALENE; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; DRUG VEHICLE; ERYTHROMYCIN; RETINOID; TETRACYCLINE;

ACNE; ANTIBIOTIC RESISTANCE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HUMAN; MAINTENANCE THERAPY; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; NAPHTHALENES;

EID: 71949097363     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09531.x     Document Type: Editorial

References (64)

1. Berson DS, Chalker DK, Harper JC et al. Current concepts in the treatment of acne: report from a clinical roundtable. Cutis 2003 72 (Suppl. 1 5 13.
2. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003 49 (Suppl. 3 200 210.
3. Tanghetti EA. Combination therapy is the standard of care. Cutis 2005 76 (Suppl. 2 8 14.
4. Gollnick H, Cunliffe W, Berson D et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003 49 (Suppl. 1 1 37.
5. Andres P, Pernin C, Poncet M. Adapalene-benzoyl peroxide once daily, fixed dose combination gel for the treatment of acne: a randomised, bilateral split-face, dose assessment study of cutaneous tolerability in healthy participants. Cutis 2008 81 : 278 284.
6. Thiboutot DM, Weiss J, Bucko A et al. Adapalene-benzoyl peroxide, a fixed dose combination for the treatment of acne vulgaris: results of a multicenter, randomised double-blind, controlled study. J Am Acad Dermatol 2007 57 : 791 799.
7. Gold LS, Tan J, Cruz-Santana A et al. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis 2009 84 : 110 116.
8. Gollnick HPM, Draelos Z, Glenn MJ et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol 2009 161 : 1180 1189.
9. Parisier DM, Westmoreland P, Morris A et al. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0·1% and benzoyl peroxide 2·5% for the treatment of acne vulgaris. J Drugs Dermatol 2007 6 : 899 905.
10. Tan JKL. Adapalene 0·1% and benzoyl peroxide 2·5%: a novel combination for the treatment of acne vulgaris. Skin Therapy Lett 2009 14 : 4 5.
11. Melnik BC, Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol 2009 18 : 833 841.
12. Trivedi NR, Cong Z, Nelson AM et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol 2006 126 : 2002 2009.
13. Böhm M, Schiller M, Ständer S et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002 11 : 533 539.
14. Pelle E, McCarthy J, Seltmann H et al. Identification of histamine receptors and reduction of squalene levels by an antihistamine in sebocytes. J Invest Dermatol 2008 128 : 1280 1285.
15. Mourelatos K, Eady EA, Cunliffe WJ et al. Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne. Br J Dermatol 2007 156 : 22 31.
16. Jeremy AH, Holland DB, Roberts SG et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003 121 : 20 7.
17. Guy R, Kealey T. Modelling the infundibulum in acne. Dermatology 1998 196 : 32 7.
18. Lyte P, Sur R, Nigam A, Southall MD. Heat-killed Propionibacterium acnes is capable of inducing inflammatory responses in skin. Exp Dermatol (in press).
19. Akaza N, Akamatsu H, Kishi M et al. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro. J Dermatol 2009 36 : 213 223.
20. Graham GM, Farrar MD, Cruse-Sawyer JE et al. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 2004 150 : 421 428.
21. Whyte A, Lynham J, Lindley E et al. Leucocyte entry and endothelial E-selectin expression following intradermal Propionibacterium acnes administration. J Comp Pathol 2000 122 : 177 184.
22. Nagy I, Pivarcsi A, Kis K et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006 8 : 2195 2205.
23. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol 2004 22 : 360 366.
24. Kang S, Cho S, Chung JH et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 2005 166 : 1691 1699.
25. Trivedi NR, Gilliland KL, Zhao W et al. Gene array expression profiling in acne lesions reveals marked up-regulation of genes involved in inflammation and matrix remodelling. J Invest Dermatol 2006 126 : 1071 1079.
26. Choi JY, Piao MS, Lee JB et al. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts. J Invest Dermatol 2008 128 : 846 854.
27. Toyoda M, Nakamura M, Morohashi M. Neuropeptides and sebaceous glands. Eur J Dermatol 2002 12 : 422 427.
28. Millikan LE. The rationale for using a topical retinoid for inflammatory acne. Am J Clin Dermatol 2003 4 : 75 80.
29. Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol 2005 4 : 41 7.
30. Vega-Diaz B, Jonard A, Michel S. Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene. J Eur Acad Dermatol 2002 16 : 123 124 (Abstract).
31. Tenaud I, Khammaru A, Dreno B. In vitro modulation of TLR-2, CD-1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol 2007 16 : 500 506.
32. Asselineau D, Cavey MT, Shroot B, Darmon M. Control of epidermal differentiation by a retinoid analogue unable to bind to cytosolic retinoic acid-binding proteins (CRABP). J Invest Dermatol 1992 98 : 128 132.
33. Griffiths CE, Elder JT, Bernard BA et al. Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol 1993 101 : 325 328.
34. Thielitz A, Adbel-Naser MB, Fluhr JW et al. Topical retinoids - an evidence-based overview. J Dtsch Dermatol Ges 2008 6 : 1023 1031.
35. Valacchi G, Rimbach G, Saliou C et al. Effect of benzoyl peroxide on antioxidant status, NF-kappaB activity and interleukin-1alpha gene expression in human keratinocytes. Toxicology 2001 165 : 225 234.
36. Iannone A, Marconi A, Zambruno G et al. Free radical production during metabolism of organic hydroperoxides by normal human keratinocytes. J Invest Dermatol 1993 101 : 59 63.
37. Shvedova AA, Tyurina JY, Karai K et al. Selective peroxidation and externalization of phosphatidylserine in normal human epidermal keratinocytes during oxidative stress induced by cumene hydroperoxide. J Invest Dermatol 2002 118 : 1008 1018.
38. Swauger JE, Dolan PM, Zweier JL et al. Role of the benzoyl oxy radical in DNA damage mediated by benzoyl peroxide. Chem Res Toxicol 1991 4 : 223 228.
39. Cove JH, Holland KT. The effect of benzoyl peroxide on cutaneous micro-organisms in vitro. J Appl Bacteriol 1983 54 : 379 382.
40. Akaike T, Sato K, Irije S et al. Bactericidal activity of alkyl peroxyl radicals generated by heme-iron-catalyzed decomposition of organic peroxides. Arch Biochem Biophys 1992 294 : 55 63.
41. Vanden Bossche H, Cornelissen F, van Cutsem J. Synergism of the antimicrobial agents miconazole and benzoyl peroxide. Br J Dermatol 1982 107 : 343 348.
42. Farmery MR, Jones CE, Eady EA et al. In vitro activity of azelaic acid, benzoyl peroxide and zinc acetate against antibiotic-resistant propionibacteria from acne patients. J Dermatolog Treat 1994 5 : 63 5.
43. Kligman AM. Acne vulgaris: tricks and treatments. Part II: the benzoyl peroxide saga. Cutis 1995 56 : 260 261.
44. Schutte H, Cunliffe WJ, Forster RA. The short-term effects of benzoyl peroxide lotion on the resolution of inflamed acne lesions. Br J Dermatol 1982 106 : 91 4.
45. Bojar RA, Cunliffe WJ, Holland KT. The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol 1995 32 : 204 208.
46. Coates P, Vyakrnam S, Eady EA et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002 146 : 840 848.
47. Ross JI, Snelling AM, Carnegie E et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003 148 : 467 478.
48. Leyden JJ. Historical perspective on the emergence of propionibacterial resistance: current views on how to combat the problem. Australasian College of Dermatologists Annual Meeting, Melbourne, 1998.
49. Oprica C, Nord CE ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005 11 : 204 213.
50. Leyden JJ, McGinley KJ, Cavalieri S. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983 8 : 41 5.
51. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989 121 : 51 7.
52. Ozolins M, Avery AJ, Eady EA et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004 364 : 2188 2195.
53. Eady EA, Farmery MR, Ross JI et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994 131 : 331 336.
54. Harkaway KS, McGinley KJ, Foglia AN et al. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol 1992 126 : 586 590.
55. Eady EA, Bojar RA, Jones CE et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin resistant propionibacteria. Br J Dermatol 1996 134 : 107 111.
56. Cunliffe WJ, Holland KT, Bojar RA, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther 2002 24 : 1117 1133.
57. Thevarajah S, Balkrishnan R, Camacho FT et al. Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment. J Dermatolog Treat 2005 16 : 224 228.
58. Kligman AM. Comparison of a topical benzoyl peroxide gel, oral minocycline, oral doxycycline and a combination for suppression of P. acnes in acne patients. J Dermatolog Treat 1998 9 : 187 191.
59. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. 2001. Available at: http://www.who.int/csr/resources/ publications/drugresist/WHO-CDS-CSR-DRS-2001-2-EN/en/ (last accessed 28 September 2009).
60. Thiboutot D, Gollnick H, Bettoli V et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne Group. J Am Acad Dermatol 2009 60 (Suppl. 5 S1 50.
61. Wolf JE Jr. Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherence. Skinmed 2004 3 : 23 6.
62. Webster G. Mechanism-based treatment of acne vulgaris: the value of combination therapy. J Drugs Dermatol 2005 4 : 281 288.
63. Zhang JZ, Li LF, Tu YT, Zheng J. A successful maintenance approach in inflammatory acne with adapalene gel 0·1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004 15 : 372 378.
64. Thiboutot DM, Shalita AR, Yamauchi PS. Adapalene gel, 0·1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006 142 : 638 640.